Skip to main content
PMC home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 2004 Feb;75(2):262–265.

A novel mutation of myelin protein zero associated with an axonal form of Charcot–Marie–Tooth disease

L Santoro 1, F Manganelli 1, M Di 1, D Bordo 1, D Cassandrini 1, F Ajmar 1, P Mandich 1, E Bellone 1
PMCID: PMC1738925  PMID: 14742601

Abstract

Objective: To report a new mutation in the MPZ gene which encodes myelin protein zero (P0), associated with an axonal form of Charcot–Marie–Tooth disease (CMT).

Methods: Three patients from an Italian family with a mild, late onset axonal peripheral neuropathy are described clinically and electrophysiologically. To detect point mutation in MPZ gene the whole coding sequence was examined. The structure of the mutated protein was investigated using the three dimensional model of P0.

Results: All patients showed a relatively mild CMT phenotype characterised by late onset and heterogeneity of the clinical and electrophysiological features. Molecular analysis demonstrated a novel heterozygous T/A transversion in the exon 3 of MPZ gene that predicts an Asp109Glu amino acid substitution in the extracellular domain of the P0. Asp109 is found at the protein surface, on ß strand E, in the interior of the P0 tetramer.

Conclusions: The identification of Asp109Glu mutation confirms the pivotal role of P0 in axonal neuropathies and stresses the phenotypic heterogeneity associated with MPZ mutations. This study suggests the value of screening for MPZ mutations in CMT family members with minor clinical and electrophysiological signs of peripheral neuropathy.

Full Text

The Full Text of this article is available as a PDF (173.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Antonellis Anthony, Ellsworth Rachel E., Sambuughin Nyamkhishig, Puls Imke, Abel Annette, Lee-Lin Shih-Queen, Jordanova Albena, Kremensky Ivo, Christodoulou Kyproula, Middleton Lefkos T. Glycyl tRNA synthetase mutations in Charcot-Marie-Tooth disease type 2D and distal spinal muscular atrophy type V. Am J Hum Genet. 2003 Apr 10;72(5):1293–1299. doi: 10.1086/375039. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bellone E., Mandich P., Mancardi G. L., Schenone A., Uccelli A., Abbruzzese M., Sghirlanzoni A., Pareyson D., Ajmar F. Charcot-Marie-Tooth (CMT) 1a duplication at 17p11.2 in Italian families. J Med Genet. 1992 Jul;29(7):492–493. [PMC free article] [PubMed] [Google Scholar]
  3. Bienfait H. M. E., Baas F., Gabreëls-Festen A. A. W. M., Koelman J. H. T. M., Langerhorst C. T., de Visser M. Two amino-acid substitutions in the myelin protein zero gene of a case of Charcot-Marie-Tooth disease associated with light-near dissociation. Neuromuscul Disord. 2002 Mar;12(3):281–285. doi: 10.1016/s0960-8966(01)00281-4. [DOI] [PubMed] [Google Scholar]
  4. Boerkoel Cornelius F., Takashima Hiroshi, Garcia Carlos A., Olney Richard K., Johnson John, Berry Katherine, Russo Paul, Kennedy Shelley, Teebi Ahmad S., Scavina Mena. Charcot-Marie-Tooth disease and related neuropathies: mutation distribution and genotype-phenotype correlation. Ann Neurol. 2002 Feb;51(2):190–201. doi: 10.1002/ana.10089. [DOI] [PubMed] [Google Scholar]
  5. Chapon F., Latour P., Diraison P., Schaeffer S., Vandenberghe A. Axonal phenotype of Charcot-Marie-Tooth disease associated with a mutation in the myelin protein zero gene. J Neurol Neurosurg Psychiatry. 1999 Jun;66(6):779–782. doi: 10.1136/jnnp.66.6.779. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. D'Urso D., Brophy P. J., Staugaitis S. M., Gillespie C. S., Frey A. B., Stempak J. G., Colman D. R. Protein zero of peripheral nerve myelin: biosynthesis, membrane insertion, and evidence for homotypic interaction. Neuron. 1990 Mar;4(3):449–460. doi: 10.1016/0896-6273(90)90057-m. [DOI] [PubMed] [Google Scholar]
  7. De Jonghe P., Timmerman V., Ceuterick C., Nelis E., De Vriendt E., Löfgren A., Vercruyssen A., Verellen C., Van Maldergem L., Martin J. J. The Thr124Met mutation in the peripheral myelin protein zero (MPZ) gene is associated with a clinically distinct Charcot-Marie-Tooth phenotype. Brain. 1999 Feb;122(Pt 2):281–290. doi: 10.1093/brain/122.2.281. [DOI] [PubMed] [Google Scholar]
  8. Ding Y., Brunden K. R. The cytoplasmic domain of myelin glycoprotein P0 interacts with negatively charged phospholipid bilayers. J Biol Chem. 1994 Apr 8;269(14):10764–10770. [PubMed] [Google Scholar]
  9. Filbin M. T., Walsh F. S., Trapp B. D., Pizzey J. A., Tennekoon G. I. Role of myelin P0 protein as a homophilic adhesion molecule. Nature. 1990 Apr 26;344(6269):871–872. doi: 10.1038/344871a0. [DOI] [PubMed] [Google Scholar]
  10. Hanemann C. O., Gabreëls-Festen A. A., De Jonghe P. Axon damage in CMT due to mutation in myelin protein P0. Neuromuscul Disord. 2001 Nov;11(8):753–756. doi: 10.1016/s0960-8966(01)00229-2. [DOI] [PubMed] [Google Scholar]
  11. Harding A. E., Thomas P. K. The clinical features of hereditary motor and sensory neuropathy types I and II. Brain. 1980 Jun;103(2):259–280. doi: 10.1093/brain/103.2.259. [DOI] [PubMed] [Google Scholar]
  12. Ismailov S. M., Fedotov V. P., Dadali E. L., Polyakov A. V., Van Broeckhoven C., Ivanov V. I., De Jonghe P., Timmerman V., Evgrafov O. V. A new locus for autosomal dominant Charcot-Marie-Tooth disease type 2 (CMT2F) maps to chromosome 7q11-q21. Eur J Hum Genet. 2001 Aug;9(8):646–650. doi: 10.1038/sj.ejhg.5200686. [DOI] [PubMed] [Google Scholar]
  13. Klein C. J., Cunningham J. M., Atkinson E. J., Schaid D. J., Hebbring S. J., Anderson S. A., Klein D. M., Dyck P. J. B., Litchy W. J., Thibodeau S. N. The gene for HMSN2C maps to 12q23-24: a region of neuromuscular disorders. Neurology. 2003 Apr 8;60(7):1151–1156. doi: 10.1212/01.wnl.0000055900.30217.ea. [DOI] [PubMed] [Google Scholar]
  14. Mandich P., Montera M., Bellone E., Trojani A., Daniele S., Ajmar F. Three novel mutations in the Von Hippel-Lindau tumour suppressor gene in Italian patients. Hum Mutat. 1998;Suppl 1:S268–S270. doi: 10.1002/humu.1380110185. [DOI] [PubMed] [Google Scholar]
  15. Marrosu M. G., Vaccargiu S., Marrosu G., Vannelli A., Cianchetti C., Muntoni F. Charcot-Marie-Tooth disease type 2 associated with mutation of the myelin protein zero gene. Neurology. 1998 May;50(5):1397–1401. doi: 10.1212/wnl.50.5.1397. [DOI] [PubMed] [Google Scholar]
  16. Mastaglia F. L., Nowak K. J., Stell R., Phillips B. A., Edmondston J. E., Dorosz S. M., Wilton S. D., Hallmayer J., Kakulas B. A., Laing N. G. Novel mutation in the myelin protein zero gene in a family with intermediate hereditary motor and sensory neuropathy. J Neurol Neurosurg Psychiatry. 1999 Aug;67(2):174–179. doi: 10.1136/jnnp.67.2.174. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Mersiyanova I. V., Perepelov A. V., Polyakov A. V., Sitnikov V. F., Dadali E. L., Oparin R. B., Petrin A. N., Evgrafov O. V. A new variant of Charcot-Marie-Tooth disease type 2 is probably the result of a mutation in the neurofilament-light gene. Am J Hum Genet. 2000 Jun 7;67(1):37–46. doi: 10.1086/302962. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Misu K., Yoshihara T., Shikama Y., Awaki E., Yamamoto M., Hattori N., Hirayama M., Takegami T., Nakashima K., Sobue G. An axonal form of Charcot-Marie-Tooth disease showing distinctive features in association with mutations in the peripheral myelin protein zero gene (Thr124Met or Asp75Val). J Neurol Neurosurg Psychiatry. 2000 Dec;69(6):806–811. doi: 10.1136/jnnp.69.6.806. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Nelis E., Timmerman V., De Jonghe P., Vandenberghe A., Pham-Dinh D., Dautigny A., Martin J. J., Van Broeckhoven C. Rapid screening of myelin genes in CMT1 patients by SSCP analysis: identification of new mutations and polymorphisms in the P0 gene. Hum Genet. 1994 Dec;94(6):653–657. doi: 10.1007/BF00206959. [DOI] [PubMed] [Google Scholar]
  20. Santoro L., Manganelli F., Di Maio L., Barbieri F., Carella M., D'Adamo P., Casari G. Charcot-Marie-Tooth disease type 2C: a distinct genetic entity. Clinical and molecular characterization of the first European family. Neuromuscul Disord. 2002 May;12(4):399–404. doi: 10.1016/s0960-8966(01)00305-4. [DOI] [PubMed] [Google Scholar]
  21. Schiavon F., Rampazzo A., Merlini L., Angelini C., Mostacciuolo M. L. Mutations of the same sequence of the myelin P0 gene causing two different phenotypes. Hum Mutat. 1998;Suppl 1:S217–S219. doi: 10.1002/humu.1380110170. [DOI] [PubMed] [Google Scholar]
  22. Senderek J., Hermanns B., Lehmann U., Bergmann C., Marx G., Kabus C., Timmerman V., Stoltenburg-Didinger G., Schröder J. M. Charcot-Marie-Tooth neuropathy type 2 and P0 point mutations: two novel amino acid substitutions (Asp61Gly; Tyr119Cys) and a possible "hotspot" on Thr124Met. Brain Pathol. 2000 Apr;10(2):235–248. doi: 10.1111/j.1750-3639.2000.tb00257.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Shapiro L., Doyle J. P., Hensley P., Colman D. R., Hendrickson W. A. Crystal structure of the extracellular domain from P0, the major structural protein of peripheral nerve myelin. Neuron. 1996 Sep;17(3):435–449. doi: 10.1016/s0896-6273(00)80176-2. [DOI] [PubMed] [Google Scholar]
  24. Takashima H., Nakagawa M., Suehara M., Saito M., Saito A., Kanzato N., Matsuzaki T., Hirata K., Terwilliger J. D., Osame M. Gene for hereditary motor and sensory neuropathy (proximal dominant form) mapped to 3q13.1. Neuromuscul Disord. 1999 Oct;9(6-7):368–371. doi: 10.1016/s0960-8966(99)00021-8. [DOI] [PubMed] [Google Scholar]
  25. Timmerman V., De Jonghe P., Spoelders P., Simokovic S., Löfgren A., Nelis E., Vance J., Martin J. J., Van Broeckhoven C. Linkage and mutation analysis of Charcot-Marie-Tooth neuropathy type 2 families with chromosomes 1p35-p36 and Xq13. Neurology. 1996 May;46(5):1311–1318. doi: 10.1212/wnl.46.5.1311. [DOI] [PubMed] [Google Scholar]
  26. Verhoeven Kristien, De Jonghe Peter, Coen Katrien, Verpoorten Nathalie, Auer-Grumbach Michaela, Kwon Jennifer M., FitzPatrick David, Schmedding Eric, De Vriendt Els, Jacobs An. Mutations in the small GTP-ase late endosomal protein RAB7 cause Charcot-Marie-Tooth type 2B neuropathy. Am J Hum Genet. 2003 Jan 21;72(3):722–727. doi: 10.1086/367847. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Warner L. E., Hilz M. J., Appel S. H., Killian J. M., Kolodry E. H., Karpati G., Carpenter S., Watters G. V., Wheeler C., Witt D. Clinical phenotypes of different MPZ (P0) mutations may include Charcot-Marie-Tooth type 1B, Dejerine-Sottas, and congenital hypomyelination. Neuron. 1996 Sep;17(3):451–460. doi: 10.1016/s0896-6273(00)80177-4. [DOI] [PubMed] [Google Scholar]
  28. Zhao C., Takita J., Tanaka Y., Setou M., Nakagawa T., Takeda S., Yang H. W., Terada S., Nakata T., Takei Y. Charcot-Marie-Tooth disease type 2A caused by mutation in a microtubule motor KIF1Bbeta. Cell. 2001 Jun 1;105(5):587–597. doi: 10.1016/s0092-8674(01)00363-4. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES